Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: judge who wrote (983)	2/4/2000 12:34:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4474

I don't have too many regrets--the process of trading is self-limiting, constantly taking money off the table and re-deploying in what you expect are better values--the difficult part of the game is predicting the speed with which the Street reacts to information, sometimes it is astonishingly slow. I think in the future I will mark down on my buy confirmations at what price I expect to give up my shares and for what reason. Gene therapy stuff is really quite amazing (no not the Yahooligan 'genetherapystuff'--don't know where he went off to). Control over the therapy, ARGENT--even more dazzling--and then this bundling, well I'm sure we are just going to hear more and more about this chemical genetics, it will be fun to get the Science paper...and I should do surf around on Pubmed and see what the Crablab and Schreiber have been cranking out lately.